PCME is an accredited provider specializing in innovative continuing medical education solutions.
PCME is an accredited provider specializing in innovative continuing medical education solutions.
Although the number of therapeutic choices for treating patients with acute thromboembolism, or those who are at risk for thromboembolic events, continues to increase; more patients than ever are developing these conditions and a majority are not achieving optimal treatment. The gap between targeted and accomplished treatment goals has serious implications for reducing morbidity and mortality associated with cardiovascular diseases that predispose to thromboembolic events. A major challenge for clinicians is deciding how to best manage patients to provide optimal clinical outcomes. Existing treatment options are generally effective, but many have significant clinical limitations, such as cumbersome dosing, lack of predictable anticoagulation, and the need for frequent monitoring and dose adjustment. Several novel oral antithrombotic/anticoagulant drugs currently in clinical development exhibit clinical and pharmacologic attributes that may address these unmet medical needs.
The proposed educational activities will help close these educational gaps among physicians who use antithrombotic/anticoagulant agents for prevention of stroke linked to atrial fibrillation and for prophylaxis and treatment of venous thromboembolism. Attendees will be able to explain the strengths and limitations of current and emerging treatment options and to discuss the potential impact of emerging treatment options on managing this patient population.
John A. Heit, , MD
Director, Coagulation Laboratory and Clinic
Consultant, Division of Cardiovascular Diseases
Professor of Medicine, College of Medicine
Mayo Clinic
Rochester, MN
Giuseppe Di Pasquale, MD, FESC, FACC
President Italian Federation of Cardiology
Director, Department of Cardiology
Maggiore Hospital
Bologna, Italy
Shannon M. Bates, MDCM, MSc, FRCP(C)
Associate Professor, Department of Medicine
McMaster University
Hamilton, Ontario
This program is intended for hematologists.
This activity was designed to address the following IOM competencies: employ evidence based practice.
At the conclusion of this activity, participants should be able to demonstrate the ability to:
Anticoagulants and antithrombotics: The current situation
John Heit, MD
Therapies for stroke prevention in atrial fibrillation
Giuseppe Di Pasquale, MD
Therapies for prevention and treatment of venous thromboembolism
Shannon Bates, MD
The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Potomac Center for Medical Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program sponsored by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.
The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
Event staff will be glad to assist you with any special needs (e.g. physical, dietary). Please email. Please email specialservices@potomacme.org at least five days prior to the program.
| Sponsored by |
This program is supported through an educational grant fromBoehringer-Ingelheim |
By clicking this button you are agreeing that you have read and understood the CME Statements above.
